{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:41:45Z","timestamp":1783528905985,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00347-025-02375-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:45:52Z","timestamp":1769597152000},"page":"154-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Okul\u00e4re Toxoplasmose im Erwachsenenalter","Ocular toxoplasmosis in adults"],"prefix":"10.1007","volume":"123","author":[{"given":"Arash","family":"Askaryanzardak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinodh","family":"Kakkassery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella Paolo","family":"Tartaglione Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Furashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hida Al-Rahman","family":"Al-Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Spyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"4","key":"2375_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3347\/kjp.2013.51.4.393","volume":"51","author":"Y-H Park","year":"2013","unstructured":"Park\u00a0Y\u2011H, Nam\u00a0H\u2011W (2013) Clinical features and treatment of ocular toxoplasmosis. Korean J Parasitol 51(4):393\u2013399. https:\/\/doi.org\/10.3347\/kjp.2013.51.4.393","journal-title":"Korean J Parasitol"},{"issue":"7","key":"2375_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","volume":"33","author":"EA Wohlfert","year":"2017","unstructured":"Wohlfert\u00a0EA, Blader\u00a0IJ, Wilson\u00a0EH (2017) Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle. Trends Parasitol 33(7):519\u2013531. https:\/\/doi.org\/10.1016\/j.pt.2017.04.001","journal-title":"Trends Parasitol"},{"key":"2375_CR3","unstructured":"https:\/\/www.rki.de\/DE\/Aktuelles\/Publikationen\/RKI-Ratgeber\/Ratgeber\/Ratgeber_Toxoplasmose.html. Zugegriffen: 10. Okt. 2025"},{"issue":"1","key":"2375_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10792-021-01994-9","volume":"42","author":"D Kalogeropoulos","year":"2021","unstructured":"Kalogeropoulos\u00a0D et\u00a0al (2021) Ocular toxoplasmosis: a\u00a0review of the current diagnostic and therapeutic approaches. Int Ophthalmol 42(1):295\u2013321. https:\/\/doi.org\/10.1007\/s10792-021-01994-9","journal-title":"Int Ophthalmol"},{"key":"2375_CR5","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2019.0435","author":"U Pleyer","year":"2019","unstructured":"Pleyer\u00a0U et\u00a0al (2019b) Toxoplasmosis in Germany: epidemiology, diagnosis, risk factors, and treatment. Dtsch \u00c4rztebl Int. https:\/\/doi.org\/10.3238\/arztebl.2019.0435","journal-title":"Dtsch \u00c4rztebl Int"},{"issue":"7","key":"2375_CR6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/09273948.2022.2117705","volume":"31","author":"EJH Goh","year":"2022","unstructured":"Goh\u00a0EJH et\u00a0al (2022) Ocular toxoplasmosis. Ocular Immunol Inflamm 31(7):1342\u20131361. https:\/\/doi.org\/10.1080\/09273948.2022.2117705","journal-title":"Ocular Immunol Inflamm"},{"issue":"12","key":"2375_CR7","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1136\/bjo.2005.083543","volume":"90","author":"MR Stanford","year":"2006","unstructured":"Stanford\u00a0MR, Tan\u00a0HK, Gilbert\u00a0RE (2006) Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a\u00a0UK survey. Br J Ophthalmol 90(12):1464\u20131467. https:\/\/doi.org\/10.1136\/bjo.2005.083543","journal-title":"Br J Ophthalmol"},{"key":"2375_CR8","doi-asserted-by":"publisher","DOI":"10.2174\/0118749445281387240202094637","author":"AR Khairullah","year":"2024","unstructured":"Khairullah\u00a0AR et\u00a0al (2024) A Comprehensive review of Toxoplasmosis: Serious Threat to Human Health. TOPHJ. https:\/\/doi.org\/10.2174\/0118749445281387240202094637","journal-title":"TOPHJ"},{"key":"2375_CR9","doi-asserted-by":"publisher","DOI":"10.7324\/japs.2020.10917","author":"TH Da Silva","year":"2020","unstructured":"Da\u00a0Silva TH, Da\u00a0SGR (2020) Therapeutic alternatives for the treatment of ocular toxoplasmosis. J\u00a0Appl Pharm Sci. https:\/\/doi.org\/10.7324\/japs.2020.10917","journal-title":"J Appl Pharm Sci"},{"key":"2375_CR10","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.96752","volume-title":"IntechOpen eBooks","author":"TK Gerges","year":"2021","unstructured":"Gerges\u00a0TK (2021) Ocular toxoplasmosis: An update on diagnosis, multimodal imaging and therapy\u2018. In: IntechOpen eBooks https:\/\/doi.org\/10.5772\/intechopen.96752"},{"key":"2375_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.actatropica.2018.04.026","volume":"185","author":"Y Zhang","year":"2018","unstructured":"Zhang\u00a0Y, Lin\u00a0X, Lu\u00a0F (2018) Current treatment of ocular toxoplasmosis in immunocompetent patients: a\u00a0network meta-analysis. Acta Trop 185:52\u201362. https:\/\/doi.org\/10.1016\/j.actatropica.2018.04.026","journal-title":"Acta Trop"},{"key":"2375_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002218.pub2","author":"E Pradhan","year":"2016","unstructured":"Pradhan\u00a0E et\u00a0al (2016) Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Libr. https:\/\/doi.org\/10.1002\/14651858.cd002218.pub2","journal-title":"Cochrane Libr"},{"issue":"2","key":"2375_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1590\/s0074-02762009000200030","volume":"104","author":"AG Commodaro","year":"2009","unstructured":"Commodaro\u00a0AG et\u00a0al (2009) Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz 104(2):345\u2013350. https:\/\/doi.org\/10.1590\/s0074-02762009000200030","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9425","key":"2375_CR14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/s0140-6736(04)16412-x","volume":"363","author":"J Montoya","year":"2004","unstructured":"Montoya\u00a0J, Liesenfeld\u00a0O (2004) Toxoplasmosis. Lancet 363(9425):1965\u20131976. https:\/\/doi.org\/10.1016\/s0140-6736(04)16412-x","journal-title":"Lancet"},{"issue":"6","key":"2375_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/09273948.2015.1057599","volume":"24","author":"M Oray","year":"2015","unstructured":"Oray\u00a0M et\u00a0al (2015) Fulminant ocular toxoplasmosis: The hazards of corticosteroid monotherapy. Ocular Immunol Inflamm 24(6):637\u2013646. https:\/\/doi.org\/10.3109\/09273948.2015.1057599","journal-title":"Ocular Immunol Inflamm"},{"key":"2375_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511527005","volume-title":"Toxoplasmosis: A\u00a0Comprehensive Clinical Guide","author":"DHM Joynson","year":"2001","unstructured":"Joynson\u00a0DHM, Wreghitt\u00a0TG (2001) Toxoplasmosis: A\u00a0Comprehensive Clinical Guide. Cambridge University Press"},{"issue":"1","key":"2375_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.ijg.0000146373.51495.c1","volume":"14","author":"AC Westfall","year":"2005","unstructured":"Westfall\u00a0AC et\u00a0al (2005) Toxoplasmosis retinochoroiditis and elevated intraocular pressure. J\u00a0Glaucoma 14(1):3\u201310. https:\/\/doi.org\/10.1097\/01.ijg.0000146373.51495.c1","journal-title":"J Glaucoma"},{"issue":"1","key":"2375_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1442-9071.2012.02838.x","volume":"41","author":"NJ Butler","year":"2012","unstructured":"Butler\u00a0NJ et\u00a0al (2012) Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol 41(1):95\u2013108. https:\/\/doi.org\/10.1111\/j.1442-9071.2012.02838.x","journal-title":"Clin Exp Ophthalmol"},{"issue":"8","key":"2375_CR19","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1080\/09273948.2020.1737142","volume":"28","author":"C Brand\u00e3o-De-Resende","year":"2020","unstructured":"Brand\u00e3o-De-Resende\u00a0C et\u00a0al (2020) Multimodal imaging in ocular toxoplasmosis. Ocular Immunol Inflamm 28(8):1196\u20131204. https:\/\/doi.org\/10.1080\/09273948.2020.1737142","journal-title":"Ocular Immunol Inflamm"},{"issue":"10","key":"2375_CR20","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/bjophthalmol-2017-311528","volume":"102","author":"T Mathis","year":"2018","unstructured":"Mathis\u00a0T et\u00a0al (2018) Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients. Br J Ophthalmol 102(10):1454\u20131458. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311528","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"2375_CR21","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1128\/jcm.00128-09","volume":"47","author":"H Talabani","year":"2009","unstructured":"Talabani\u00a0H et\u00a0al (2009) Contributions of immunoblotting, Real-Time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. J\u00a0Clin Microbiol 47(7):2131\u20132135. https:\/\/doi.org\/10.1128\/jcm.00128-09","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2375_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0161-6420(13)31267-6","volume":"101","author":"BS Elkins","year":"1994","unstructured":"Elkins\u00a0BS et\u00a0al (1994) Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology 101(3):499\u2013507. https:\/\/doi.org\/10.1016\/s0161-6420(13)31267-6","journal-title":"Ophthalmology"},{"key":"2375_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1403025","author":"Z Chen","year":"2024","unstructured":"Chen\u00a0Z et\u00a0al (2024) New advances in immune mechanism and treatment during ocular toxoplasmosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1403025","journal-title":"Front Immunol"},{"issue":"1","key":"2375_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000449169","volume":"57","author":"C Ozgonul","year":"2016","unstructured":"Ozgonul\u00a0C, Besirli\u00a0CG (2016) Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res 57(1):1\u201312. https:\/\/doi.org\/10.1159\/000449169","journal-title":"Ophthalmic Res"},{"issue":"2","key":"2375_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00347-022-01691-7","volume":"120","author":"A Taghavi-Eraghi","year":"2022","unstructured":"Taghavi-Eraghi\u00a0A et\u00a0al (2022) Diagnostik und Behandlung der okul\u00e4ren Toxoplasmose. Ophthalmologie 120(2):191\u2013199","journal-title":"Ophthalmologie"},{"key":"2375_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00057-17","author":"IR Dunay","year":"2018","unstructured":"Dunay\u00a0IR et\u00a0al (2018) Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/cmr.00057-17","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"2375_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova\u00a0A et\u00a0al (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115(4):517\u2013523. https:\/\/doi.org\/10.1016\/s0002-9394(14)74456-3","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"2375_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1080\/09273948.2020.1735450","volume":"28","author":"A De-La-Torre","year":"2020","unstructured":"De-La-Torre\u00a0A, G\u00f3mez-Mar\u00edn\u00a0J (2020) Disease of the Year 2019: Ocular toxoplasmosis in HIV-infected patients. Ocular Immunol Inflamm 28(7):1031\u20131039. https:\/\/doi.org\/10.1080\/09273948.2020.1735450","journal-title":"Ocular Immunol Inflamm"},{"issue":"4","key":"2375_CR29","doi-asserted-by":"publisher","first-page":"e0283845","DOI":"10.1371\/journal.pone.0283845","volume":"18","author":"C Cifuentes-Gonz\u00e1lez","year":"2023","unstructured":"Cifuentes-Gonz\u00e1lez\u00a0C et\u00a0al (2023b) Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A\u00a0systematic review and meta-analysis. Plos One 18(4):e283845. https:\/\/doi.org\/10.1371\/journal.pone.0283845","journal-title":"Plos One"},{"issue":"1","key":"2375_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10792-012-9634-1","volume":"33","author":"N Baharivand","year":"2012","unstructured":"Baharivand\u00a0N, Mahdavifard\u00a0A, Fouladi\u00a0RF (2012) Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a\u00a0prospective randomized clinical trial. Int Ophthalmol 33(1):39\u201346. https:\/\/doi.org\/10.1007\/s10792-012-9634-1","journal-title":"Int Ophthalmol"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-025-02375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-025-02375-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-025-02375-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:19:43Z","timestamp":1770139183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-025-02375-8"}},"subtitle":["Refresher","Refresher course"],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1007\/s00347-025-02375-8","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"A.\u00a0Askaryanzardak\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt an der Klinik f\u00fcr Unfallchirurgie des Universit\u00e4tsklinikum OWL am Standort Detmold.\n                      V.\u00a0Kakkassery\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt der Klinik f\u00fcr Augenheilkunde der Klinikum Chemnitz gGmbH.\n                      G.P.\u00a0Tartaglione Gracia\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Assistenz\u00e4rztin an der Klinik f\u00fcr Unfallchirurgie des Universit\u00e4tsklinikum OWL am Standort Detmold.\n                      O.\u00a0Furashova\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellte \u00c4rztin: stellvertretende Chef\u00e4rztin der Klinik f\u00fcr Augenheilkunde, Klinikum Chemnitz | Mitgliedschaften: Deutsche Retinologische Gesellschaft, EURETINA.\n                      H.A.-R.\u00a0Al-Badri\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Angestellter Assistenzarzt in Klinik f\u00fcr Augenheilkunde Klinikum Chemnitz gGmbH, Chemnitz | Mitgliedschaften: DOG (Section Uveitis und Kornea).\n                      S.\u00a0Spyra\n                      gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Assistenzarzt an der Augenklinik des Klinikum Chemnitz.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}